Guardant Non Currrent Assets Other vs Non Current Liabilities Total Analysis
GH Stock | USD 25.36 0.88 3.35% |
Guardant Health financial indicator trend analysis is much more than just examining Guardant Health latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Guardant Health is a good investment. Please check the relationship between Guardant Health Non Currrent Assets Other and its Non Current Liabilities Total accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
Non Currrent Assets Other vs Non Current Liabilities Total
Non Currrent Assets Other vs Non Current Liabilities Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Guardant Health Non Currrent Assets Other account and Non Current Liabilities Total. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Guardant Health's Non Currrent Assets Other and Non Current Liabilities Total is 0.91. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Guardant Health, assuming nothing else is changed. The correlation between historical values of Guardant Health's Non Currrent Assets Other and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Guardant Health are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Non Currrent Assets Other i.e., Guardant Health's Non Currrent Assets Other and Non Current Liabilities Total go up and down completely randomly.
Correlation Coefficient | 0.91 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.Non Current Liabilities Total
Most indicators from Guardant Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Guardant Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.As of now, Guardant Health's Tax Provision is increasing as compared to previous years. The Guardant Health's current Issuance Of Capital Stock is estimated to increase to about 517.8 M, while Selling General Administrative is projected to decrease to under 118.7 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 250.7M | 293.2M | 336.9M | 177.0M | Total Revenue | 373.7M | 449.5M | 563.9M | 282.4M |
Guardant Health fundamental ratios Correlations
Click cells to compare fundamentals
Guardant Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Guardant Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 962.5M | 2.3B | 2.2B | 1.6B | 1.8B | 1.4B | |
Short Long Term Debt Total | 33.3M | 847.9M | 1.4B | 1.4B | 1.4B | 685.2M | |
Other Current Liab | 37.1M | 44.3M | 152.9M | (21.9M) | 108.3M | 113.7M | |
Total Current Liabilities | 72.7M | 66.8M | 194.7M | 193.2M | 205.9M | 112.0M | |
Total Stockholder Equity | 798.4M | 1.3B | 645.0M | 60.2M | 158.7M | 150.7M | |
Other Liab | 8.6M | 1.5M | 3.9M | 9.2M | 8.3M | 6.7M | |
Net Tangible Assets | 779.7M | 1.3B | 627.5M | 45.2M | 51.9M | 49.3M | |
Property Plant And Equipment Net | 72.8M | 100.1M | 313.9M | 341.9M | 302.7M | 163.8M | |
Current Deferred Revenue | 12.3M | 8.6M | 11.3M | 17.4M | 18.0M | 12.2M | |
Net Debt | (110.0M) | 14.9M | 868.7M | 1.2B | 220.2M | 274.0M | |
Retained Earnings | (352.8M) | (606.6M) | (1.0B) | (1.7B) | (2.1B) | (2.0B) | |
Accounts Payable | 16.2M | 7.3M | 17.6M | 175.8M | 51.7M | 39.5M | |
Cash | 143.2M | 833.0M | 492.2M | 141.6M | 1.1B | 1.2B | |
Non Current Assets Total | 365.2M | 383.4M | 1.1B | 418.4M | 439.3M | 402.7M | |
Non Currrent Assets Other | 4.9M | 17.2M | 60.9M | 61.5M | 124.2M | 130.4M | |
Other Assets | 4.9M | 17.2M | 60.9M | 36.5M | 41.9M | 44.0M | |
Cash And Short Term Investments | 522.8M | 1.8B | 932.7M | 1.0B | 1.2B | 847.8M | |
Net Receivables | 48.0M | 53.3M | 97.7M | 97.3M | 88.8M | 60.1M | |
Common Stock Shares Outstanding | 90.6M | 97.5M | 101.3M | 102.2M | 112.0M | 92.9M | |
Short Term Investments | 379.6M | 961.9M | 440.5M | 869.6M | 35.1M | 33.3M | |
Liabilities And Stockholders Equity | 962.5M | 2.3B | 2.2B | 1.6B | 1.8B | 1.4B | |
Non Current Liabilities Total | 41.8M | 849.4M | 1.4B | 1.4B | 1.4B | 1.5B | |
Capital Surpluse | 1.2B | 1.9B | 1.7B | 1.7B | 2.0B | 1.1B | |
Capital Lease Obligations | 40.4M | 41.6M | 226.1M | 231.9M | 213.8M | 224.5M | |
Inventory | 15.2M | 22.7M | 30.7M | 51.6M | 61.9M | 65.0M | |
Other Current Assets | 11.4M | 17.5M | 53.1M | 31.5M | 27.7M | 20.6M | |
Other Stockholder Equity | 1.2B | 1.9B | 1.7B | 1.7B | 2.3B | 1.3B | |
Total Liab | 114.5M | 916.2M | 1.6B | 1.5B | 1.6B | 1.7B | |
Property Plant And Equipment Gross | 72.8M | 100.1M | 313.9M | 341.9M | 430.0M | 451.5M | |
Total Current Assets | 597.4M | 1.9B | 1.1B | 1.2B | 1.3B | 956.1M | |
Accumulated Other Comprehensive Income | 1.1M | 2.7M | (4.8M) | (19.5M) | (3.7M) | (3.9M) | |
Non Current Liabilities Other | 8.6M | 43.1M | 3.9M | 9.2M | 96.0M | 100.8M | |
Short Term Debt | 7.1M | 6.6M | 12.9M | 21.9M | 28.0M | 29.3M | |
Property Plant Equipment | 72.8M | 62.8M | 313.9M | 167.9M | 193.1M | 106.4M | |
Net Invested Capital | 798.4M | 2.1B | 1.8B | 1.2B | 1.3B | 1.2B | |
Net Working Capital | 524.6M | 1.8B | 919.4M | 998.4M | 1.1B | 950.8M | |
Intangible Assets | 15.4M | 16.2M | 14.2M | 11.7M | 9.0M | 13.1M |
Currently Active Assets on Macroaxis
When determining whether Guardant Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Guardant Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Guardant Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Guardant Health Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.92) | Revenue Per Share 5.171 | Quarterly Revenue Growth 0.309 | Return On Assets (0.17) | Return On Equity (38.84) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.